Navigation Links
Ian Tomlinson Joins SBC Board as GlaxoSmithKline Representative Director
Date:10/19/2011

STEVENAGE, England, October 19, 2011 /PRNewswire/ --

Stakeholder representative to guide development of UK's first open innovation bioscience campus

Stevenage Bioscience Catalyst (SBC), the UK's first open innovation bioscience campus, is pleased to announce that Ian Tomlinson, Senior Vice President, Head of Biopharmaceuticals R&D and Worldwide Business Development at GlaxoSmithKline, has been appointed to its Board.

In his role as GSK Representative Director, Dr Tomlinson will bring his experience of innovation in both the large and small company environment to SBC. Prior to joining GSK, he spent 11 years at the MRC Laboratory of Molecular Biology in Cambridge.  In 2000, together with Sir Gregory Winter, he co-founded Domantis Limited to develop a new class of drugs based on domain antibodies. Domantis was acquired by GSK in 2007. Following Dr Tomlinson's appointment to the SBC Board, Dr Allan Baxter, formerly Chairman and GSK representative, becomes Independent Chairman.

Dr Martino Picardo, CEO of Stevenage Bioscience Catalyst, said, "Having Ian, with his entrepreneurial and large company expertise, on our Board as a stakeholder representative is a great advantage as we work to make Stevenage Bioscience Catalyst a compelling offering for life sciences companies. In particular, development of our open innovation offering will be greatly enhanced by the network he brings in his business development role at GSK."

Dr Ian Tomlinson added, "Stevenage Bioscience Catalyst will be an important player in the UK life sciences ecosystem, and I am delighted to be working with the team to build on the progress it has made so far. In this role I will be helping to bring new companies to the site, as well as encouraging scientific collaboration to advance translation of research ideas and early discovery into new medicines and technologies."

Stevenage Bioscience Catalyst is a joint venture between the Department of Business, I
'/>"/>

SOURCE Stevenage Bioscience Catalyst
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Luminex Corporation Joins Forces With the National Marrow Donor Program - Be The Match®
2. Amyris Chief Joins Renmatix BoD, New CFO Added to Company
3. Noted Author, Speaker, and Publisher, Gary Barg Joins BRAVE Awards Selection Committee
4. Eric Tornoe Joins Exagen Diagnostics as President and COO
5. Kelly Price Joins Los Angeles County Affiliate of Susan G. Komen for the Cure in the Fight Against Breast Cancer
6. Andrea Drucker Joins Insmed as General Counsel
7. Coloredge New York - Los Angeles Joins DuPont™ Tyvek® Graphics Authorized Printer Network
8. Jeff Sherman Joins Block Engineering as Vice President of Worldwide Sales
9. Laszlo Radvanyi, Ph.D. Joins Genesis Biopharma Scientific and Medical Advisory Board
10. Dr. Joel Posener Joins PharmaNet as Executive Medical Director, Neuroscience
11. Eduard Alberts, Ph.D. Joins Sanford Rose Associates - San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... GERMANTOWN, Md. , Aug. 3, 2015   ... it will release first half and second quarter 2015 ... 10 th , 2015.  The Company will host a ... results and provide a general business update. ... (Domestic US) and 1-412-902-4262 (International), and asking to join ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... analysis and premium industry insights on the global resorcinol industry. The report highlights ... study of vivid market scenarios and analysis of primary and secondary inputs from ...
(Date:7/30/2015)... 2015   GenoSpace , a leading provider ... analysis of genomic and other biomedical data, today ... the company as Vice President of Sales and ... "GenoSpace partners with its customers ... and explore complex sets of genomic, phenotypic and ...
(Date:7/30/2015)... Kan. , July 30, 2015   ... a pet therapeutics company focused on the licensing, ... companion animals, today announced that its strategic partner ... a dose confirmation study of AT-016, an adipose-derived ... for the treatment of osteoarthritis pain in dogs. ...
Breaking Biology Technology:Intrexon to Announce First Half and Second Quarter 2015 Financial Results and Host Conference Call on August 10th 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5
...   Life Technologies Corporation (NASDAQ: LIFE ... Association Francaise de Normalisation (AFNOR) for its MicroSEQ® ... Listeria monocytogenes assays, molecular tests that are ... absence of this food-borne pathogen that most recently has ...
... that it has modified the provisions of its American Depository ... Limited ordinary shares for each ADR share will now be ... change will be effective from 3 January, 2012.  The change ... number of outstanding common shares the company has on issue ...
... (NASDAQ: HALO) will be presenting at the 30th Annual ... January 11, 2012 at 2:00 p.m. PT / 5:00 ... and chief executive officer of Halozyme Therapeutics, will provide ... The presentation will be webcast through the ...
Cached Biology Technology:Life Technologies Receives AFNOR Validation for Tests Designed to Detect Listeria Contamination in Food Samples 2Life Technologies Receives AFNOR Validation for Tests Designed to Detect Listeria Contamination in Food Samples 3Life Technologies Receives AFNOR Validation for Tests Designed to Detect Listeria Contamination in Food Samples 4
(Date:7/30/2015)... Calif. , July 30, 2015 ... services for gene function analysis and biomarker discovery, ... RNA (sgRNA) Knockout Library targeting all human protein ... and permanently "knock out" a gene,s function. Cellecta,s ... a high throughput screening tool so that researchers ...
(Date:7/23/2015)... Inc. (NASDAQ: AWRE ), a leading supplier of biometrics ... quarter ended June 30, 2015.  Revenue for ... of 33% compared to $6.8 million in the same quarter ... was $0.3 million, or $0.01 per diluted share, which compared ... same period a year ago.  Lower revenue ...
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4
... cognitive impairment is a transitional stage between normal ... during this transformation have yet to be studied. ... of Technology, China constructed brain networks using resting-state ... populations (normal controls, patients with early mild cognitive ...
... drink changed how cells lining the nasal passages of hay ... did not lead to significant changes in hay fever symptoms, ... allergen exposure., Our immune system must distinguish between "friends" that ... have harmful effects. There is now a growing body ...
... is available in German . ... the establishment of nine new Collaborative Research Centres (CRCs). This was ... in Bonn. The new CRCs will receive a total of 64.4 ... months and a 20% programme allowance for indirect project costs . ...
Cached Biology News:Researchers have a nose for how probiotics could affect hay fever 2DFG establishes 9 new collaborative research centers 2DFG establishes 9 new collaborative research centers 3DFG establishes 9 new collaborative research centers 4DFG establishes 9 new collaborative research centers 5DFG establishes 9 new collaborative research centers 6
... Microarrays designed for genome-wide microRNA expression ... and powerful Paraflo microfluidic on-chip synthesis ... part of our comprehensive microRNA Expression ... The Fishes microRNA Microarray contains ...
...
... CP-4900 is a rugged, compact, ... the information you need - ... composition of gas mixtures is ... Chromatograph generates more data in ...
... an exciting new chapter to ... leadership, Agilents 7890A GC gives ... take your lab to the ... GC/MS performance, including advanced separation ...
Biology Products: